升主动脉孤立性腔内修复的早期结局与时间趋势:全国多中心注册研究
基于SVS-VQI数据库,纳入55例仅累及0区的升主动脉TEVAR患者,技术成功率94.5%,围术期死亡率14.5%、卒中1.8%,3年免于主动脉再干预率83.2%;围术期死亡率从早期队列25.9%降至当代队列3.6%(P=0.025)。
要点
- 0区孤立性升主动脉TEVAR技术成功率94.5%,围术期死亡率14.5%、卒中1.8%。
- 3年免于主动脉再干预率83.2%,1年及3年免于卒中率均为97.5%。
- 围术期死亡率从早期队列25.9%降至当代队列3.6%(P=0.025)。
核心结论
- 对于经选择的高危患者,仅累及0区的升主动脉TEVAR可行,围术期结局可接受,卒中与内漏率低,中期耐久性良好。
- 结局随时间显著改善,提示机构经验与多学科专长的重要性。
研究设计与样本
- 回顾性查询SVS-VQI TEVAR注册数据库至2026年4月,纳入仅累及0区的升主动脉腔内修复患者。
- 手术由28个VQI中心、36名术者完成,排除近端或远端锚定区超出0区的患者。
- 分析基线特征、手术变量、围术期结局及中期生存,采用Kaplan-Meier法估计总生存及免于卒中、内漏、主动脉再干预率,并比较早期与当代队列的时间效应。
主要发现
- 共55例患者接受仅累及0区的升主动脉TEVAR,中位年龄75岁,多数合并显著心血管合并症。
- 总技术成功52例(94.5%),中位手术时间110分钟,中位住院4天。
- 围术期死亡率14.5%,卒中发生率1.8%;1年及3年免于卒中率均为97.5%。
- 免于主动脉再干预率1年为91.5%,3年为83.2%。
- 围术期死亡率从早期队列25.9%降至当代队列3.6%(P=0.025)。
临床怎么用
- 对于不适合常规开放手术的高危0区主动脉病变患者,可考虑仅累及0区的升主动脉TEVAR。
- 围术期需重点关注死亡风险,尤其早期经验阶段,并强调机构经验与多学科协作。
- 中期随访应监测卒中、内漏及主动脉再干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular repair of the ascending aorta has emerged as a minimally invasive alternative for high-risk patients with zone 0 aortic pathology who are unsuitable for conventional open repair. This study evaluated perioperative outcomes, midterm durability, and temporal era effects associated with ascending thoracic endovascular aortic repair (TEVAR) using the Society for Vascular Surgery Vascular Quality Initiative (SVS-VQI) database. METHODS: The SVS-VQI TEVAR registry was queried through April 2026 to identify patients undergoing endovascular repair confined to zone 0. Procedures were performed across 28 participating VQI centers by 36 operators. Patients with proximal or distal landing zones extending beyond zone 0 were excluded. Baseline characteristics, procedural variables, perioperative outcomes, and midterm survival were analyzed. Kaplan-Meier analysis was used to estimate overall survival and freedom from stroke, endoleak, and aortic reintervention. Temporal era effects were evaluated by comparing early and contemporary procedural cohorts. RESULTS: A total of 55 patients underwent ascending TEVAR confined to zone 0. The median age was 75 years, and most patients had significant cardiovascular comorbidity. Overall technical success was achieved in 52 patients (94.5%). The median operative duration was 110 minutes, and the median hospital stay was 4 days. Perioperative mortality was 14.5%, whereas stroke occurred in 1.8% of patients. Freedom from stroke was 97.5% at both 1 and 3 years. Freedom from aortic reintervention was 91.5% at 1 year and 83.2% at 3 years. Perioperative mortality decreased significantly from 25.9% in the early cohort to 3.6% in the contemporary cohort (P = 0.025), suggesting improved outcomes with increasing procedural experience. CONCLUSION: Ascending TEVAR confined to zone 0 is feasible with acceptable perioperative outcomes, low stroke and endoleak rates, and favorable midterm durability in selected high-risk patients. Significant improvement in outcomes over time highlights the importance of institutional experience and multidisciplinary expertise.
引用
- Baghbani A, Dominguez G, Tanaka A, et al. Isolated Endovascular Repair of the Ascending Aorta: Early Outcomes and Temporal Trends from a National Multicenter Registry. Ann Vasc Surg. 2026. PMID: 42342212. doi:10.1016/j.avsg.2026.06.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。